VivoSim Labs, Inc. (LON:0R02)
London · Delayed Price · Currency is GBP · Price in USD 3.174
+0.065 (2.09%)
At close: Mar 20, 2025
VivoSim Labs Market Cap
VivoSim Labs has a market cap or net worth of 7.32 million as of September 17, 2025. Its market cap has increased by 4.21% in one year.
Market Cap
7.32M
Enterprise Value
1.28M
Revenue
103.65K
Ranking
n/a
PE Ratio
n/a
Stock Price
3.17
Market Cap Chart
Since February 14, 2012, VivoSim Labs's market cap has decreased from 36.80M to 7.32M, a decrease of -80.12%. That is a compound annual growth rate of -11.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 7.32M | 29.59% |
| Dec 31, 2024 | 5.64M | -33.94% |
| Dec 29, 2023 | 8.55M | -16.20% |
| Dec 30, 2022 | 10.20M | -56.31% |
| Dec 31, 2021 | 23.34M | -61.52% |
| Dec 31, 2020 | 60.65M | 73.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 175.94B |
| GSK plc | 58.89B |
| Haleon | 30.40B |
| Smith & Nephew | 11.94B |
| ConvaTec Group | 4.69B |
| Hikma Pharmaceuticals | 3.58B |
| HUTCHMED (China) | 2.12B |
| Genus | 1.65B |